Pathologically, CD5+ DLBCL are associated with centroblastic morphology (rarely immunoblastic), Bcl-2 overexpression, and non-germinal center B-cell (non-GCB) subtype [16,19]. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.